Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01HBE
|
||||
Former ID |
DNC014774
|
||||
Drug Name |
RHIZOXIN
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Discontinued in Phase 2 | [544988] | ||
Structure |
Download2D MOL |
||||
Formula |
C35H47NO9
|
||||
Canonical SMILES |
CC1C=CC2C(O2)(C(CC(OC(=O)C3C(O3)CC4CC1OC(=O)C4)C(C)C(C(<br />=CC=CC(=CC5=COC(=N5)C)C)C)OC)O)C
|
||||
InChI |
1S/C35H47NO9/c1-19(13-25-18-41-23(5)36-25)9-8-10-21(3)32(40-7)22(4)27-17-29(37)35(6)30(45-35)12-11-20(2)26-14-24(16-31(38)42-26)15-28-33(43-28)34(39)44-27/h8-13,18,20,22,24,26-30,32-33,37H,14-17H2,1-7H3/b9-8+,12-11?,19-13+,21-10+/t20-,22+,24+,26-,27+,28+,29+,30-,32+,33-,35+/m1/s1
|
||||
InChIKey |
OWPCHSCAPHNHAV-DLABXAFDSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin | Target Info | Inhibitor | [528337] | |
Tubulin beta | Target Info | Inhibitor | [528337] | ||
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.